title: Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract.
abstract: Twenty-three consecutive patients with advanced squamous carcinoma of the lower female genital tract were entered into a pilot study to determine the response rate and toxicity of a combination of intravenous cisplatin and 5-fluorouracil given concomitantly with radiation therapy. Twenty (87%) of the patients had a complete clinical response. Two patients (9%) had a partial response and one (4%) had stable disease. Nine (45%) of the complete responders have recurred with a median time to recurrence of 4 months. Seven (35%) had some component of local recurrence. The complete responders who have not recurred have been followed a median of 17 months. The acute toxicity was generally mild and there was no life-threatening acute complications. Three patients developed significant late complications. The response rate in this study was very high. The responses were usually prompt and dramatic, but often not sustained.
authors.affiliation: H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa 33682.
authors.forename: W S
authors.initials: WS
authors.lastname: Roberts
authors.forename: J J
authors.initials: JJ
authors.lastname: Kavanagh
authors.forename: H
authors.initials: H
authors.lastname: Greenberg
authors.forename: S C
authors.initials: SC
authors.lastname: Bryson
authors.forename: J P
authors.initials: JP
authors.lastname: LaPolla
authors.forename: P A
authors.initials: PA
authors.lastname: Townsend
authors.forename: M S
authors.initials: MS
authors.lastname: Hoffman
authors.forename: D
authors.initials: D
authors.lastname: Cavanagh
authors.forename: S
authors.initials: S
authors.lastname: Hewitt
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D014625:Vaginal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D014846:Vulvar Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy
chemical_list: D002945:Cisplatin; D005472:Fluorouracil